Moffitt’s Malignant Hematology physicians and scientists were proud to share and present their research findings at American Society of Clinical Oncology (ASCO 2022) Read More
Loss of the BCL-2 amplicon and transcriptional reprogramming contribute to resistance to the drug Venetoclax® for those with B-cell lymphomas Read More
Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data Read More
The first one on the list of Moffitt's top research developments for 2017 is the FDA approval of CAR T therapy for certain aggressive types of adult lymphoma. Read More
New ZUMA-1 trial data published in The New England Journal of Medicine report long-term measurable remission rates 15 months following treatment with Yescarta™ Read More
Dr. Frederick Locke, vice chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy, answers some frequently asked questions about CAR T cell therapy. Read More
The U.S. Congress has designated September as Blood Cancer Awareness Month. Moffitt Cancer Center is pleased to join in this effort as a way to educate the general public and provide support, strength and hope to individuals who are affected by blood cancer. Read More
Approximately every four minutes, someone in the United States is diagnosed with leukemia, lymphoma or another type of cancer that affects the blood cells, bone marrow or lymphatic system. Read More
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate button below. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub